Welcome to LookChem.com Sign In|Join Free

CAS

  • or

53750-66-6

Post Buying Request

53750-66-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53750-66-6 Usage

General Description

4-Chloro-pyridine-2-carbonyl chloride is a chemical compound that is commonly used in organic synthesis and pharmaceutical research. It is a chlorinated derivative of pyridine, which is a heterocyclic aromatic compound. The carbonyl chloride group makes this compound reactive and useful as a building block for creating various organic compounds. It is often used as an intermediate in the manufacturing of pharmaceuticals and agrochemicals. This chemical has a wide range of applications in the research and development of new drugs and agricultural products. However, it is important to handle 4-Chloro-pyridine-2-carbonyl chloride with care due to its reactivity and potential hazards.

Check Digit Verification of cas no

The CAS Registry Mumber 53750-66-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,7,5 and 0 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 53750-66:
(7*5)+(6*3)+(5*7)+(4*5)+(3*0)+(2*6)+(1*6)=126
126 % 10 = 6
So 53750-66-6 is a valid CAS Registry Number.
InChI:InChI=1/C6H3Cl2NO/c7-4-1-2-9-5(3-4)6(8)10/h1-3H

53750-66-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-Chloro-pyridine-2-carbonyl chloride

1.2 Other means of identification

Product number -
Other names 4-chloropicolinoyl chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53750-66-6 SDS

53750-66-6Relevant articles and documents

Remarkably Efficient Iridium Catalysts for Directed C(sp2)-H and C(sp3)-H Borylation of Diverse Classes of Substrates

Chattopadhyay, Buddhadeb,Hassan, Mirja Md Mahamudul,Hoque, Md Emdadul

supporting information, p. 5022 - 5037 (2021/05/04)

Here we describe the discovery of a new class of C-H borylation catalysts and their use for regioselective C-H borylation of aromatic, heteroaromatic, and aliphatic systems. The new catalysts have Ir-C(thienyl) or Ir-C(furyl) anionic ligands instead of the diamine-type neutral chelating ligands used in the standard C-H borylation conditions. It is reported that the employment of these newly discovered catalysts show excellent reactivity and ortho-selectivity for diverse classes of aromatic substrates with high isolated yields. Moreover, the catalysts proved to be efficient for a wide number of aliphatic substrates for selective C(sp3)-H bond borylations. Heterocyclic molecules are selectively borylated using the inherently elevated reactivity of the C-H bonds. A number of late-stage C-H functionalization have been described using the same catalysts. Furthermore, we show that one of the catalysts could be used even in open air for the C(sp2)-H and C(sp3)-H borylations enabling the method more general. Preliminary mechanistic studies suggest that the active catalytic intermediate is the Ir(bis)boryl complex, and the attached ligand acts as bidentate ligand. Collectively, this study underlines the discovery of new class of C-H borylation catalysts that should find wide application in the context of C-H functionalization chemistry.

METHODS OF USING REBASTINIB IN THE TREATMENT OF DISORDERS

-

Paragraph 0467, (2021/09/10)

Described herein are methods of treating various disorders in patients in need thereof, comprising administering to the patient the compound of Formula (I) or a pharmaceutically acceptable salt thereof. Exemplary disorders that can be treated by the methods described herein include gynecologic carcinosarcomas, endometrial adenocarcinomas, mesotheliomas, ovarian cancers, pancreatic ductal adenocarcinomas, and lung cancers.

Picolinamide compound containing triazole or quinolinone structure and application of picolinamide compound

-

Paragraph 0104; 0107-0108; 0229-0230, (2020/01/12)

The invention provides a picolinamide compound containing a triazole or quinolinone structure and application of the picolinamide compound. According to a technical scheme in the invention, extensiveresearch is conducted on the picolinamide compound, and

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 53750-66-6